Posts Tagged ‘x57s’

Vitamin D on Trial | The Scientist

Thursday, June 1st, 2017

#VitaminD on Trial
http://the-Scientist.com/2012/03/01/vitamin-d-on-trial Interesting mail the med. trial where participants aren’t explicitly checked for compliance

QT:{{”

“Once a month for the next 5 years, 20,000 people across the United States will find a package containing 62 pills in their mailboxes. As participants in a clinical trial, the recipients agreed to swallow two of the pills daily. But inevitably as the years pass, some pill packets will become buried under a stack of letters, or forgotten in a drawer. After all, these pills contain only vitamin D, fish oil, or an inert placebo—a person doesn’t need them to make it through the day. Plus, no one monitors who takes the pills daily and who does not.”

….

Scientists critical of the VITAL study question whether the daily dose of 2,000 IU is enough to distinguish the treatment group from the controls. If this were a drug trial, the placebo group would go without the drug completely. But it’s unethical to ask anyone to go without vitamin D. Doctors inform all participants that they can take up to 800 IU of vitamin D daily (the national recommendation for people over 70 years old) in addition to the pills they receive in the mail. If they do, the control group will sustain more than adequate levels. But some participants might decide to break the rules and head to the nearest corner store for high-dose supplements after being told that vitamin D may help prevent cancer and other diseases. And of course, many participants won’t follow through with taking the pills they’ve been sent in the mail. “You hope drop-ins and drop-outs will be equal on both sides, but they may not be,” warns biostatistician Gary Cutter at the University of Alabama at Birmingham.

A higher dose of vitamin D would widen the gap between the treatment and the control group, but Manson isn’t swayed. She says 2,000 IU will lift the treatment arm well above the level suggested to help protect against nonskeletal diseases, while she expects the controls to stabilize at levels sufficient for healthy bones. “Sure, we could have tested higher doses, but then right off the bat, we might have had safety issues,” Manson says.

Nonetheless, in other disease-prevention trials, investigators are gunning for better compliance and a fighting chance of showing an effect by doling out large, periodic doses of vitamin D. In the United Kingdom, a trial looking at the effect of vitamin D on respiratory infections (including the flu) is giving participants 120,000 IU of the vitamin every 2 months. And participants in the treatment arm of a vitamin D trial for type 2 diabetes prevention take an average dose of 89,684 IU once per week.
“}}

Slide Rules: Gone But Not Forgotten » American Scientist

Tuesday, May 23rd, 2017

#SlideRules: Gone But Not Forgotten http://www.AmericanScientist.org/issues/pub/2017/3/slide-rules-gone-but-not-forgotten Live on in logos & architecture + the desire to estimate orders of magnitude

How DNA Editing Could Change Life on Earth

Thursday, February 23rd, 2017

QT:{{”
“One of Esvelt’s goals at M.I.T. is to facilitate that shift. Part of his job, as he sees it, is to challenge what he describes as “the ridiculous notion that natural and good are the same thing.” Instead, he told me, we ought to think about intelligent design as an instrument of genetics. He smiled because the phrase “intelligent design” usually refers to the anti-Darwinian theory that the universe, with all its intricacies and variations, is too complex to have arisen by chance—that there had to be a guiding hand. The truth is more prosaic, and also more remarkable: for four billion years, evolution, driven by natural selection and random mutation, has insured that the most efficient genes would survive and the weakest would disappear. But, propelled by CRISPR and other tools of synthetic biology, intelligent design has taken on an entirely new meaning, one that threatens to transcend Darwin—because evolution may soon be guided by us.”
“}}

How DNA Editing Could Change Life on Earth
http://www.NewYorker.com/magazine/2017/01/02/rewriting-the-code-of-life Intelligent design from CRISPR & gene drive rather than natural selection

The complete list of Siri commands – CNET

Monday, February 20th, 2017

Some ones l liked.

QT:{{”

Schedule or cancel a meeting. Ex.: “Schedule a meeting with [name] tomorrow at 11:30 a.m.” or “Cancel my 5 p.m. appointment.”

Set location-aware reminders. Ex.: “Remind me to remember my keys when I leave,” or “Remind me to feed the dog when I get home.”

Set alarms. Ex.: “Set an alarm for 1 a.m.” or “Set an alarm for six hours from now.”

Delete/turn off all alarms. Ex. “Delete all alarms” or “Turn off all alarms.”

Check the number of days between dates. Ex.: “How many days until October 6?” or “How many days between April 3 and June 16?”

Send an email. Ex.: “Send email to [name] about [subject] and say [message].”

Set a timer. Ex.: “Set the timer for 10 minutes.”
Check the weather. Ex.: “What’s the weather like today?” or “Do I need an umbrella?”

Random tips and tricks:

Find out what airplanes are currently flying above you. Ex.: “What airplanes are above me?”
Roll a die or roll two dice.
Tell me a joke.
What does the fox say?
Knock knock.
Who’s on first?
Why did the chicken cross the road?
What is zero divided by zero?
Learn how to say my name.
“}}

https://www.cnet.com/how-to/the-complete-list-of-siri-commands/

The Heroism of Incremental Care

Sunday, February 19th, 2017

The Heroism of Incremental Care, by @Atul_Gawande
http://www.newyorker.com/magazine/2017/01/23/the-heroism-of-incremental-care Positively compares GPs-v-surgeons to bridge inspectors v rescuers

QT:{{”
“For a long time, this would have seemed as foolish as giving your money to a palmist. What will happen to a bridge—or to your body—fifty years from now? We had no more than a vague idea. But the
investigation of the 1967 Silver Bridge collapse marked an advance in our ability to shift from reacting to bridge catastrophes to anticipating and averting them.

Around the same time, something similar was happening in medicine. Scientists were discovering the long-term health significance of high blood pressure, diabetes, and other conditions. We’d begun collecting the data, developing the computational capacity to decode the patterns, and discovering the treatments that could change them. Seemingly random events were becoming open to prediction and alteration. Our frame of medical consideration could widen to encompass our entire life spans.


Our ability to use information to understand and reshape the future is accelerating in multiple ways. We have at least four kinds of information that matter to your health and well-being over time: information about the state of your internal systems (from your imaging and lab-test results, your genome sequencing); the state of your living conditions (your housing, community, economic, and environmental circumstances); the state of the care you receive (what your practitioners have done and how well they did it, what
medications and other treatments they have provided); and the state of your behaviors (your patterns of sleep, exercise, stress, eating, sexual activity, adherence to treatments). The potential of this information is so enormous it is almost scary.

Instead of once-a-year checkups, in which people are like bridges undergoing annual inspection, we will increasingly be able to use smartphones and wearables to continuously monitor our heart rhythm, breathing, sleep, and activity, registering signs of illness as well as the effectiveness and the side effects of treatments. Engineers have proposed bathtub scanners that could track your internal organs for minute changes over time. We can decode our entire genome for less than the cost of an iPad and, increasingly, tune our care to the exact makeup we were born with.

Our health-care system is not designed for this future—or, indeed, for this present. We built it at a time when such capabilities were virtually nonexistent. When illness was experienced as a random catastrophe, and medical discoveries focussed on rescue, insurance for unanticipated, episodic needs was what we needed. Hospitals and heroic interventions got the large investments; incrementalists were scanted. After all, in the nineteen-fifties and sixties, they had little to offer that made a major difference in people’s lives. But the more capacity we develop to monitor the body and the brain for signs of future breakdown and to correct course along the way—to deliver “precision medicine,” as the lingo goes—the greater the difference health care can make in people’s lives, as well as in reducing future costs.”
“}}

Software or softwear?

Sunday, February 19th, 2017

#Software or softwear?
https://www.1843magazine.com/style/software-or-softwear Appears fashions change faster for computers than clothes. Cf
http://www.SFChronicle.com/opinion/openforum/article/Going-beyond-geek-chic-CeBIT-6883249.php?t=a28a0bfcd600af33be&cmpid=twitter-premium

QT:{{”
For years now I’ve written about fancy-schmancy clothes, shoes and bags. I’ve visited factories and ateliers across Europe to observe artisans make Hermès bags, Kiton suits, Berluti jeans, Tod’s loafers, Mulberry luggage, Private White VC jackets, John Lobb Oxfords, Brunello Cucinelli sweaters – and much more besides. I love watching skilled craftsmen going about their business, then trying to explain the process in print without resorting to hype.

But buying the stuff? Despite my privileged access and my love of beautiful things, whenever push comes to shoving my hand into my pocket and slapping down the moolah, I tend to cringe: £600 ($750) for a pair of shoes? A £900 coat? A £3,000 watch? Uh-uh.

I tell myself that my hesitation is based on prudence. I’ve got kids to feed, after all, and the closest I’ve come to planning for the future is booking a hotel in Paris. Yet when it comes to another retail category that dominates this golden age of consumer capitalism – personal technology – it’s another story.

Ever since my childish paws first caressed the orange plastic contours of my beloved Texas Instruments Speak & Spell, I’ve been a sucker for a screen, a shutter-click or a bleep. From my first computer (an Amstrad CPC464), first camera (a Pentax me Super) and first mobile phone (a Sony Ericsson whose model number eludes me – maybe it fried the relevant synapse), I can chart each period in my life according to the hardware I was using. And I’ve never felt anything but virtuous about forking out when the cash was, briefly, in hand. Why? Because personal tech is the toolbox of 21st-century life. It empowers. It frees. It improves.

But last month I had an epiphany. It happened as I sat in the Genius Bar of an Apple store feeling stupid, paying £300 to repair the suddenly blank screen of a laptop purchased not much more than a year earlier. The cheery Genius at hand had told me that in my position, he’d probably just buy a new computer: “but that’s just me”, he said, “I always want the latest model.”

Briefly, that technophile, Pavlovian response kicked in: woof! Lead me to the newest, most expensive version! But it was swiftly replaced by a howl of inner fury.

More and more, I observe technology companies adopting the marketing strategies of luxury-goods firms. Sure, their narrative focuses not on heritage or trends, but on incremental upgrades in processing speeds, peripheral capabilities and software compatibility. Yet many companies talk just as enthusiastically about design as functionality, and propose that owning their products is a declaration of personal identity. Each new launch inevitably presents whatever product is being pitched as the ne plus ultra of its type – a big fat lie that becomes ever more glaring as the cycle of enforced obsolescence spins faster and faster.

I’ve spent the last week or so sifting through my personal archive of the obsolete: à la recherche du tech perdu. From tangles of cable and brick-like batteries I’ve excavated minidisc players (Sanyo!), BlackBerrys, Nokias, ThinkPads, iMacs, a Google Glass, Coolpix and more. None, of course, is fit for purpose now, unless you’re going to a “Back to the Future” party.”
“}}

The Troll of Internet Art

Friday, February 17th, 2017

The Troll of Internet Art
http://www.NewYorker.com/magazine/2017/01/30/brad-troemel-the-troll-of-internet-art When #virality is the goal, how to separate art & commerce? Cf http://TheJogging.Tumblr.com/

Timeline | Bulletin of the Atomic Scientists

Monday, February 6th, 2017

http://thebulletin.org/timeline

currently 2.5′ to midnight

Doomsday Prep for the Super-Rich – The New Yorker

Sunday, February 5th, 2017

Doomsday Prep for the Super-Rich
http://www.NewYorker.com/magazine/2017/01/30/doomsday-prep-for-the-super-rich Holing up in New Zealand & the survival condo; a bit validating for normal worriers

QT:{{”
“The tech preppers do not necessarily think a collapse is likely. They consider it a remote event, but one with a very severe downside, so, given how much money they have, spending a fraction of their net worth to hedge against this . . . is a logical thing to do.”

You’re basically seeing that the people who’ve been the best at reading the tea leaves—the ones with the most resources, because that’s how they made their money—are now the ones most preparing to pull the rip cord and jump out of the plane.”

Every year since 1947, the Bulletin of the Atomic Scientists, a magazine founded by members of the Manhattan Project, has gathered a group of Nobel laureates and other luminaries to update the Doomsday Clock, a symbolic gauge of our risk of wrecking civilization. In 1991, as the Cold War was ending, the scientists set the clock to its safest point ever—seventeen minutes to “midnight.”
“}}

Building a Brain in the Lab – Scientific American

Tuesday, January 31st, 2017

Building a Brain in the Lab
https://www.ScientificAmerican.com/article/building-a-brain-in-the-lab/ Nice summary of the development of organoids & their promise for personalized treatments